11
TITLE: Host-directed strategies using lipid nanoparticles to reduce mycobacteria survival  Full Text
AUTHORS: Pereira, L; Diogo, J; Mateus, R; Pimentel, M; Videira, M;
PUBLISHED: 2015, SOURCE: JOURNAL OF NANOPARTICLE RESEARCH, VOLUME: 17, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
12
TITLE: EMT Blockage Strategies: Targeting Akt Dependent Mechanisms for Breast Cancer Metastatic Behaviour Modulation
AUTHORS: Rafael, D; Doktorovova, S; Florindo, HF; Gener, P; Abasolo, I; Jr. Schwartz; Videira, MA;
PUBLISHED: 2015, SOURCE: CURRENT GENE THERAPY, VOLUME: 15, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
13
TITLE: Solid state formulations composed by amphiphilic polymers for delivery of proteins: characterization and stability  Full Text
AUTHORS: Fernanda Andrade; Pedro Fonte; Mireia Oliva; Mafalda Videira; Domingos Ferreira ; Bruno Sarmento ;
PUBLISHED: 2015, SOURCE: INTERNATIONAL JOURNAL OF PHARMACEUTICS, VOLUME: 486, ISSUE: 1-2
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
14
TITLE: Implications of Akt2/Twist crosstalk on breast cancer metastatic outcome  Full Text
AUTHORS: Lucilia Pereira; Sara Horta; Rita Mateus; Mafalda A Videira;
PUBLISHED: 2015, SOURCE: DRUG DISCOVERY TODAY, VOLUME: 20, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
15
TITLE: Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells  Full Text
AUTHORS: Petra Gener; Luis Pleno Gouveia; Guillem R Romero Sabat; Diana Fernandes D de Sousa Rafael; Nuria B Bergada Fort; Alexandra Arranja; Yolanda Fernandez; Rafael M Minana Prieto; Joan S Sayos Ortega; Diego Arango; Ibane Abasolo; Mafalda Videira; Simo Schwartz;
PUBLISHED: 2015, SOURCE: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, VOLUME: 11, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
16
TITLE: Preclinical development of siRNA therapeutics: Towards the match between fundamental science and engineered systems  Full Text
AUTHORS: Videira, M; Arranja, A; Rafael, D; Gaspar, R;
PUBLISHED: 2014, SOURCE: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, VOLUME: 10, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
17
TITLE: Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance  Full Text
AUTHORS: Mafalda Videira; Rita Leones Reis; Maria Alexandra Brito;
PUBLISHED: 2014, SOURCE: BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, VOLUME: 1846, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
18
TITLE: Characterisation of DM-beta-cyclodextrin:prednisolone complexes and their formulation as eye drops  Full Text
AUTHORS: Andre Sa Couto; Joana Vieira; Helena F Florindo; Mafalda A Videira; Helena M Cabral Marques;
PUBLISHED: 2014, SOURCE: JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, VOLUME: 80, ISSUE: 1-2
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
19
TITLE: Looking out for Cancer Stem Cells' Properties: The Value-Driving Role of CD44 for Personalized Medicines
AUTHORS: Sara Horta; Ana Lucia Agostinho; Rita Mateus; Lucilia Pereira; Carolina Pereira; Liliana Capinha; Slavomira Doktorovova; Alexandra Brito; Mafalda Videira;
PUBLISHED: 2014, SOURCE: CURRENT CANCER DRUG TARGETS, VOLUME: 14, ISSUE: 9
INDEXED IN: Scopus WOS
IN MY: ORCID
20
TITLE: Regulatory Aspects of Oncologicals: Nanosystems Main Challenges
AUTHORS: Rogério S Gaspar; Helena F Florindo; Liana C Silva; Mafalda A Videira; Luísa L Corvo; Bárbara F Martins; Beatriz Silva-Lima;
PUBLISHED: 2014, SOURCE: Nano-Oncologicals - Advances in Delivery Science and Technology
INDEXED IN: CrossRef
IN MY: ORCID
Page 2 of 3. Total results: 27.